{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 462258437
| IUPAC_name = 2-(naphthalen-1-ylmethyl)-4,5-dihydro-1''H''-imidazole
| image = Naphazoline.svg
| width = 175
| image2 = Naphazoline.png
| width2 = 175

<!--Clinical data-->
| tradename = Naphcon-a
| Drugs.com = {{drugs.com|monograph|naphazoline-hydrochloride}}
| pregnancy_category =  
| legal_status =  
| routes_of_administration = Topical ([[solution]])

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| excretion =

<!--Identifiers-->
| IUPHAR_ligand = 5509
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 835-31-4
| ATC_prefix = R01
| ATC_suffix = AA08
| ATC_supplemental = {{ATC|S01|GA01}}
| PubChem = 4436
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB06711
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4283
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = H231GF11BV
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08253
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 761

<!--Chemical data-->
| C=14 | H=14 | N=2 
| molecular_weight = 210.274
| smiles = N\1=C(\NCC/1)Cc2cccc3c2cccc3
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C14H14N2/c1-2-7-13-11(4-1)5-3-6-12(13)10-14-15-8-9-16-14/h1-7H,8-10H2,(H,15,16)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = CNIIGCLFLJGOGP-UHFFFAOYSA-N
}}

'''Naphazoline''' (in the hydrochloride form) is the common name for 2-(1-naphthylmethyl)-2-imidazoline hydrochloride. It is a [[sympathomimetic]] agent with marked [[Adrenergic receptor|alpha adrenergic]] activity. It is a [[vasoconstrictor]]  with a rapid action in reducing swelling when applied to [[mucous membrane]]. It acts on alpha-receptors in the [[arterioles]] of the [[conjunctiva]] to produce constriction, resulting in decreased congestion. It is an [[active ingredient]] in several over-the-counter formulations including '''Clear Eyes''' and '''Naphcon''' [[eye drop]]s.<ref>{{cite encyclopedia | author = Green, S. M. | year = 2008 | title = Ophthalmology: Naphazoline | encyclopedia = Tarascon Pocket Pharmacopoeia 2009 | publisher = Jones and Bartlett | isbn = 0-7637-6572-4 }}</ref>

The non-hydrochloride form of Naphazoline has the [[Chemical formula|molecular formula]] C<sub>14</sub>H<sub>14</sub>N<sub>2</sub> and a [[molar mass]] of 210.28 g/mol. The HCl salt form has a molar mass of 246.73 g/mol.

==Warnings and contraindications==
A few warnings and [[contraindications]] that apply to all naphazoline-containing substances intended for medicinal use are:

* Hypersensitivity to naphazoline
* Patients taking [[Monoamine oxidase inhibitor|MAO inhibitors]] can experience a severe [[hypertension|hypertensive]] crisis if given a [[sympathomimetic]] drug such as naphazoline HCl
* Use in infants and children can result in [[central nervous system]] depression, leading to coma and marked reduction in [[Thermoregulation|body temperature]]
* Should be used with caution in patients with severe [[cardiovascular disease]] including [[cardiac arrhythmia]] and in patients with [[diabetes]], especially those with a tendency toward diabetic [[ketoacidosis]]
* Drug interactions can occur with [[anaesthetics]] that sensitize the [[myocardium]] to sympathomimetics (e.g. [[cyclopropane]] or [[halothane]] cautiously)
* Exercise caution when applying prior to use of [[phenylephrine]].
* Extended use may cause [[rhinitis medicamentosa]], a condition of [[Rebound effect|rebound]] [[nasal congestion]].

A possible association with stroke has been suggested.<ref name="pmid15476091">{{cite journal |author1=Zavala, J. A. |author2=Pereira, E. R. |author3=Zétola, V. H. |author4=Teive, H. A. |author5=Nóvak, E. M. |author6=Werneck, L. C. | title = Hemorrhagic stroke after naphazoline exposition: case report | journal = Arquivos de Neuro-Psiquiatria | year = 2004 | volume = 62 | issue = 3B | pages = 889–891 | pmid = 15476091 | doi = 10.1590/S0004-282X2004000500030  | url = http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2004000500030&lng=en&nrm=iso&tlng=en }}</ref>

==References==
{{reflist}}

{{Adrenergic agonists}}
{{Nasal preparations}}

[[Category:Alpha-adrenergic agonists]]
[[Category:Decongestants]]
[[Category:Imidazolines]]
[[Category:Naphthalenes]]